GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Covalon Technologies Ltd (OTCPK:CVALF) » Definitions » Stock Based Compensation

Covalon Technologies (Covalon Technologies) Stock Based Compensation : $0.39 Mil (TTM As of Dec. 2023)


View and export this data going back to 2007. Start your Free Trial

What is Covalon Technologies Stock Based Compensation?

Covalon Technologies's Stock Based Compensation for the three months ended in Dec. 2023 was $0.09 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Dec. 2023 was $0.39 Mil.


Covalon Technologies Stock Based Compensation Historical Data

The historical data trend for Covalon Technologies's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Covalon Technologies Stock Based Compensation Chart

Covalon Technologies Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Stock Based Compensation
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.30 0.54 0.13 0.16 0.41

Covalon Technologies Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.12 0.12 0.08 0.09 0.09

Covalon Technologies Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.39 Mil.


Covalon Technologies Stock Based Compensation Related Terms

Thank you for viewing the detailed overview of Covalon Technologies's Stock Based Compensation provided by GuruFocus.com. Please click on the following links to see related term pages.


Covalon Technologies (Covalon Technologies) Business Description

Traded in Other Exchanges
Address
1660 Tech Avenue, Unit 5, Mississauga, ON, CAN, L4W 5S7
Covalon Technologies Ltd is principally engaged in the business of developing, licensing, and selling medical technologies. The company develops advanced wound care line which is designed for the treatment of a wide range of wounds; and infection prevention products such as MediClear PreOp which is a breathable, transparent, self-adhesive silicone barrier film that conforms to the contours of the body. It also develops perioperative care products. The company generates its revenue through development contracts, licensing agreements, and distribution contracts, and sales.